Board of Directors

The board works on a voluntary basis. It manages the association’s business and is responsible for all matters not assigned to the general meeting.

Mitglieder des Vorstandes 2023-2025

Dr. Paul Hadrossek

Chairman

Dr Paul Hadrossek supports companies in innovation strategies, advises investors on investment issues, their portfolio companies and start-ups. This was preceded by work as a research assistant and senior physician at the University Hospital of Münster, as well as setting up a dental care centre. The development of a company builder for the healthcare sector and, as a result, the founding of the telemedicine company Kinderheldin in 2017 were important milestones for him. With Kinderheldin, he was part of the SVDGV founding companies, with the aim of jointly enabling digital health solutions to find a sustainable way into healthcare. Dr Paul Hadrossek has been an elected member of the board of directors of the SVDGV since 2020 and has been chairman of the board of directors since October 2023.

Dr. Anna Haas

1st Vice Chairwoman

Dr Anna Haas is Managing Director of Oviva Germany and also responsible for Oviva France. Oviva helps people with weight-related medical conditions by providing an accessible and effective therapy. Prior to Oviva, Dr Anna Haas was Managing Director at Shire Pharmaceuticals in Ireland and Project Manager at McKinsey & Company in Europe and Asia. She studied biochemistry at the University of Potsdam and obtained a doctorate in immunology at ETH Zurich.

Henrik Emmert

2. Vice Chairman

Henrik Emmert is co-founder and CEO of aidhere GmbH, a digital health company founded in 2019. The first product of aidhere GmbH is the digital obesity therapy ‘zanadio’. In November 2020, the programme was one of the first applications to be approved by the German Federal Institute for Drugs and Medical Devices as a digital health application (DiGA) and included in the list of prescribable products.
Prior to this, the industrial engineer worked as a principal at the Boston Consulting Group, advising international companies in the healthcare sector.

Previously, the industrial engineer was a principal at the Boston Consulting Group, advising international companies in the healthcare sector.

Markus C. Müller

Board member & treasurer

Markus C. Müller is CEO and co-founder of Nui Care, which is developing a digital platform for caregiving relatives. He studied law at the LMU in Munich and founded his first software company while still a student. He sold it to BlackBerry in 2011. There he rose to become head of the European division before leaving in 2015 to train as a volunteer hospice worker. It was through this work that he came into contact with caregiving and caregiving relatives. He founded Nui Care to provide digital support for this group.

Dr. Julian Braun

Board member

Dr. iur. Julian Braun has been a member of the board of the SVDGV and legal advisor to the association since 2019. In this role, he deals with all health law issues at the SVDGV, plays a leading role in negotiating important industry framework agreements for the digital health industry (including the DiGA and DiPA framework agreements), prepares the association’s statements on BMG draft legislation, is a member of the joint DiGA body and regularly conducts arbitration proceedings for member companies. As General Counsel Medical Law at Ada Health GmbH, Julian Braun focuses on emerging international legal issues that affect Ada GmbH’s global business and play a role in the area of regulation for medical device software and artificial intelligence. In addition, advising on digital health and health insurance law issues is another focus of his work.

Anisa Idris

Board member

Anisa Idris joined the SVDGV in 2020 and deals with patent and reimbursement law issues. In this role, she also co-led the negotiation for 13 manufacturer associations in the DiGA Framework Agreement negotiation with Julian Braun.
With her team at Ada Health, Anisa works on global reimbursement strategies, taking into account medical device law issues. She has 15 years of experience in pharmaceutical management, including her previous role as Director for Digital Innovation & Performance, where she was responsible for the strategic direction of all digital activities of the individual Novartis Pharma national companies in the European region of Novartis Pharma AG and led the health care management contracting of Novartis Pharma in Germany.

Dr. med. Christoph Twesten

Board member

Dr Christoph Twesten is a co-founder of Perfood GmbH, which manufactures the DiGA app. He brings his expertise as head of the working group on data protection to the association and supports the SVDGV in shaping the data protection and security landscape for the DiGA ecosystem. He began his medical career by successfully completing his medical studies in 2012. He then worked as a doctor of internal medicine at the University Medical Center Schleswig-Holstein in Lübeck from 2013 to 2017. In 2017, he co-founded the DiGA manufacturer Perfood (www.perfood.de), where he has served as Chief Technology Officer ever since. In this role, Dr Twesten is not only responsible for technical progress and innovation; he also oversees the medical device approval processes and the implementation of artificial intelligence in the product development process. His expertise encompasses not only medicine but also in-depth knowledge of software development, which he has gained from numerous software projects since childhood.